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Abstract
Background and Purpose: To understand the mechanisms involved in the strong
killing effect of carbon-ion beam irradiation on cancer cells with TP53 tumor
suppressor gene deficiencies.
Materials and Methods: DNA damage responses after carbon-ion beam or X-ray
irradiation in isogenic HCT116 colorectal cancer cell lines with and without TP53 (p53+/
+ and p53-/-, respectively) were analyzed as follows: cell survival by clonogenic assay,
cell death modes by morphologic observation of DAPI-stained nuclei, DNA double-
strand breaks (DSBs) by immunostaining of phosphorylated H2AX (cH2AX), and cell
cycle by flow cytometry and immunostaining of Ser10-phosphorylated histone H3.
Results: The p53-/- cells were more resistant than the p53+/+ cells to X-ray
irradiation, while the sensitivities of the p53+/+ and p53-/- cells to carbon-ion beam
irradiation were comparable. X-ray and carbon-ion beam irradiations predominantly
induced apoptosis of the p53+/+ cells but not the p53-/- cells. In the p53-/- cells,
carbon-ion beam irradiation, but not X-ray irradiation, markedly induced mitotic
catastrophe that was associated with premature mitotic entry with harboring long-
retained DSBs at 24 h post-irradiation.
Conclusions: Efficient induction of mitotic catastrophe in apoptosis-resistant p53-
deficient cells implies a strong cancer cell-killing effect of carbon-ion beam
irradiation that is independent of the p53 status, suggesting its biological advantage
over X-ray treatment.
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Introduction
Carbon-ion radiotherapy has been provoking interest in the field of cancer
therapy. Carbon-ion beams have advantageous properties over X-ray; a superior
dose distribution associated with the sharp penumbra and the Bragg peak, and
strong cell-killing effect [1, 2]. The major promising clinical outcome of carbon-
ion radiotherapy is to overcome the therapeutic resistance of cancer cells to X-ray
radiotherapy. For example, a recent study in which carbon-ion radiotherapy was
used to treat patients with rectal cancer reported a 5-year local control and overall
survival rates of 97% and 51% for post-operative recurrent cases [3]. This rate is
superior to the 5-year overall survival rates (0240%) that are typically achieved by
conventional X-ray radiotherapy or surgical resection [3, 4]. However, the
biological basis for the strong cell-killing effect of carbon-ion beam irradiation on
X-ray-resistant tumors has not been elucidated fully.
Genetic aberrations contribute to the X-ray resistance of cancer cells [5, 6].
Inactivating mutations in the tumor suppressor gene TP53 are representative of
tumor resistance, and these aberrations are associated with poor prognosis after
X-ray radiotherapy [7, 8]. The p53 protein plays multiple roles in the DNA
damage response (DDR) to X-ray irradiation, including the regulation of cell
death pathways and cell cycle checkpoints [9]. The induction of apoptosis by p53
is a key factor affecting the sensitivity of cancer cells to X-ray radiation. Several
pre-clinical and clinical studies have demonstrated that TP53 mutations are
associated with the resistance of cancer cells to X-ray irradiation therapy
[7, 10, 11].
Previous studies showed that carbon-ion beam irradiation effectively kills X-
ray-resistant p53-mutant cancer cells [12––15]. Although the mechanisms
involved in this process were examined in these studies, the results were
inconsistent. The inconsistencies are likely attributable to the fact that each study
focused on only a few aspects of the DDR (such as apoptosis or the cell cycle
response) [12–15] and each used cancer cell lines with different genetic
backgrounds; hence, the effects of aberrations in genes other than TP53 may have
masked the results [12, 13]. Here, to clarify the mechanisms underlying the strong
killing effect of carbon-ion beam irradiation on X-ray irradiation-resistant cancer
cells with TP53 aberrations, we performed a comprehensive study of multiple




Human colorectal cancer HCT116 cells harboring wild-type p53 (p53+/+) and its
isogenic p53-null derivative (p53-/-) were provided by Dr. B. Vogelstein of Johns
Hopkins University. HCT116 p53+/+ cells have intact DNA damage checkpoints
[16]. p53 expression, and the effects of X-ray and carbon-ion beam irradiation on
p53 expression in p53+/+ and p53-/- cells, was examined by immunoblotting with
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antibodies against p53 (Santa Cruz) and b-actin (loading control, Cell Signaling
Technology) (S1a Fig.). There was no significant difference in the population
doubling time between the two cell lines (S1b Fig.).
Human colon cancer (RKO, LS123, and WiDr) cells, human lung cancer
(H1299) cells, and human osteosarcoma (Saos-2) cells were purchased from
ATCC. RKO cells harbor wild-type p53. LS123 and WiDr cells harbor a missense
mutation in p53 at R175H and R273H, respectively. H1299 and Saos-2 cells are
p53-null. H1299 cells stably expressing a p53 missense mutation (R175H, R273H,
R249S or R280K) were established as described previously [17]. All cells were
cultured in RPMI-1640 medium supplemented with 10% fetal bovine serum.
hTERT-immortalized normal human diploid foreskin fibroblasts (BJ-hTERT)
harboring wild-type p53 were purchased from Clontech. BJ-hTERT cells
expressing shRNA against EGFP (BJ-hTERT-WT; control) or p53 (BJ-hTERT-
shp53) were established as previously described [18], and cultured in Minimum
Essential Eagle’s Medium.
Irradiation
X-ray irradiation was performed using a Faxitron RX-650 radiation source (100
kVp, 1.14 Gy/min; Faxitron Bioptics). Carbon-ion beam irradiation was
performed at Gunma University Heavy Ion Medical Center using the same beam
specifications that are used in clinical settings (290 MeV/nucleon and an average
linear energy transfer (LET) at the center of a 6 cm spread-out Bragg peak of
approximately 50 keV/mm). Carbon-ion beams were delivered in a vertical
direction so that cells on culture plates can receive the dose evenly.
Clonogenic survival assay
Cells were seeded into 6-well plates and exposed (or not) to X-ray or carbon-ion
beam irradiation. After incubation for a further 10 days, the cells were fixed with
methanol and stained with crystal violet. Colonies of at least 50 cells were counted.
The surviving fraction was normalized to the corresponding controls. The dose
that resulted in a surviving fraction of 10% (D10) was calculated using the linear-
quadratic model, as described previously [19].
Cell death evaluations
Cells were grown on glass coverslips, exposed (or not) to X-ray or carbon-ion
beam irradiation, and then stained with 4’,6-diamidino-2-phenylindole dihy-
drochloride (DAPI), as described previously [20]. Confocal images were collected
using a BX51 microscope (Olympus) equipped with a CCD camera (VB-7000;
Keyence). Apoptosis was determined based on the morphology of the nuclei,
including the presence of apoptotic bodies, nuclear condensation and fragmen-
tation [21]. Cells containing nuclei with two or more distinct lobes were scored as
positive for mitotic catastrophe [20, 22]. Cells containing nuclei showing
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senescence-associated heterochromatic foci were scored as positive for senescence
[23]. The percentages of cells undergoing apoptosis, mitotic catastrophe or
senescence were quantified by counting at least 300 cells for each experimental
condition.
Cell cycle analysis
Cells exposed (or not) to X-ray or carbon-ion beam irradiation were harvested at
the indicated time points, fixed with ethanol, stained with propidium iodide in
the presence of RNase, and then analyzed using flow cytometry, as described
previously [19].
Immunostaining
Cells exposed (or not) to X-ray or carbon-ion beam irradiation were stained with
antibodies against Ser139-phosphorylated histone H2AX (cH2AX; Millipore) or
Ser10-phosphorylated histone H3 (pH3; Millipore), as described previously [24].
cH2AX foci per nucleus were scored in sequential 2D images captured from
multiple focal planes. At least 500 cells were evaluated for each experimental
condition.
Statistical analysis
Experiments were performed in triplicate at least unless otherwise stated.
Statistically significant differences were determined by unpaired Student’s t-tests
using StatMateIII ver. 3.17 software (ATMS). P,0.05 was considered significant.
Results
Carbon-ion beams have more potent cancer cell-killing activity
than X-rays irrespective of the p53 status
The sensitivities of p53+/+ and p53-/- HCT116 cells to X-ray and carbon-ion beam
irradiation were assessed by clonogenic survival assays (Fig. 1). As expected based
on the results of previous studies [14, 15], p53-/- cells were more resistant to X-ray
irradiation than p53+/+ cells; the D10 values for these two cell lines were 6.8 Gy and
3.8 Gy, respectively. By contrast, the sensitivities of p53+/+ and p53-/- cells to
carbon-ion beam irradiation were comparable; the D10 values for these cell lines
were 1.7 Gy and 1.9 Gy, respectively. Hence, the relative biological effectiveness of
carbon-ion beam irradiation to X-ray irradiation at D10 was 2.2 in p53
+/+ cells and
3.6 in p53-/- cells. These data indicate that carbon-ion beam irradiation effectively
kills X-ray-resistant p53-null cancer cells.
Carbon-Ion Beam-Induced Cell Death and p53 Status
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Aberrations in p53 switch the mode of irradiation-induced cancer
cell death from apoptosis to mitotic catastrophe
To explore the mechanisms underlying the p53 status-independent cell-killing
activity of carbon-ion beam irradiation, the modes of cell death induced by X-ray
or carbon-ion beam irradiation were assessed (Figs. 2, 3). p53+/+ and p53-/- cells
were irradiated with doses of X-ray or carbon-ion beams that were similar to the
D10 for p53
+/+ cells (X-ray, 4 Gy; carbon-ion beams, 1.5 Gy). Apoptosis, mitotic
catastrophe and senescence were determined by examining the characteristic
morphologies of nuclei stained with DAPI (Fig. 2a–c) [20–23]. In p53+/+ cells,
apoptosis was the dominant mode of cell death induced by X-ray and carbon-ion
beam irradiation (Figs. 2d, f, 3a). By contrast, p53-/- cells were less susceptible to
apoptosis caused by both types of irradiation (Figs. 2e, g, 3b). Interestingly, in
p53-/- cells, carbon-ion beam irradiation induced mitotic catastrophe more
evidently than X-ray irradiation (Figs. 2g, 3b). A higher dose of X-ray irradiation
equivalent to the D10 (6.8 Gy) for p53
-/- cells induced a similar level of mitotic
catastrophe to that induced by carbon-ion beam irradiation at 1.5 Gy (S2 Fig.).
The induction of senescence was not evident in all experimental conditions
(Fig. 2). This result was confirmed by senescence-associated b-galactosidase
staining assays, in which the fraction of staining-positive cells was less than 2% for
both cell lines exposed to X-ray or carbon-ion beam irradiation (data not shown).
These data indicated that apoptosis and mitotic catastrophe is the major mode of
cell death in p53+/+ cells and p53-/- cells, respectively, both after exposure to X-ray
and carbon-ion beam irradiation, and that carbon-ion beam irradiation induces
mitotic catastrophe more effectively than X-ray irradiation in apoptosis-resistant
p53-/- cells.
To investigate this further, we examined the mode of cell death in multiple
human cell lines with differing p53 status after X-ray or carbon-ion beam
Fig. 1. Sensitivity of p53+/+ and p53-/- HCT116 cells to X-ray and carbon-ion beam irradiation as
assessed by clonogenic survival assays. Cells were seeded in 6-well plates, incubated overnight, and then
exposed to X-ray or carbon-ion beam irradiation. After incubation for a further 10 days, the cells were fixed,
stained, and counted. The surviving fraction was normalized to the value of the corresponding controls. Data
are expressed as the mean ¡ SD. C-ion, carbon-ion.
doi:10.1371/journal.pone.0115121.g001
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Fig. 2. Mode of cell death induced by X-ray or carbon-ion beam irradiation in p53+/+ and p53-/- HCT116
cells. Cells seeded on glass coverslips were incubated overnight, exposed (or not; 0 h) to X-ray (4 Gy) or
carbon-ion beam (1.5 Gy) irradiation, and then stained with DAPI. Apoptosis, mitotic catastrophe, and
senescence were determined according to the characteristic nuclear morphologies (see ‘‘Materials and
methods’’ for the definitions). (a–c) Representative images showing the nuclear morphology of cells
undergoing apoptosis (a), mitotic catastrophe (b), or senescence (c). The images of p53-/- cells were taken
72 h after carbon-ion beam irradiation. (d, e) Mode of cell death in p53+/+ (d) and p53-/- (e) cells at 0, 12, 24,
48, 72, 96 and 120 h after X-ray irradiation. (f, g) Mode of cell death in p53+/+ (f) and p53-/- (g) cells at 0, 12,
24, 48, 72, 96 and 120 h after carbon-ion beam irradiation. IR, irradiation; C-ion, carbon-ion.
doi:10.1371/journal.pone.0115121.g002
Carbon-Ion Beam-Induced Cell Death and p53 Status
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irradiation (Fig. 4). RKO cells harboring wild-type p53 showed an apoptosis-
dominant phenotype after either X-ray or carbon-ion beam irradiation, whereas
p53-null H1299 and Saos-2 cells showed a mitotic catastrophe-dominant
phenotype. Accordingly, suppression of p53 expression in BJ-hTERT fibroblasts
promoted the induction of mitotic catastrophe upon X-ray or carbon-ion beam
irradiation (S3 Fig.). Interestingly, LS123 and WiDr cells (expressing p53
harboring a missense at R175H and R273H, respectively), also showed a mitotic
catastrophe-dominant phenotype (Fig. 4). These mutation sites are located within
the DNA-binding domain of the p53 protein, which plays a key role in the
transcriptional activation of several target genes, including those involved in
apoptosis induction [25]. Therefore, we next examined the mode of irradiation-
induced cell death using a series of isogenic H1299 cells stably expressing p53
proteins harboring missense mutations in the DNA-binding domain that are often
observed in human cancers (i.e., R175H, R273H, R249S and R280K) [25]. All of
Fig. 3. Representative images of p53+/+ and p53-/- HCT116 cells irradiated with carbon-ion beams. Cells
were seeded on glass coverslips, incubated overnight, exposed to carbon-ion beams (1.5 Gy), and then
stained with DAPI 72 h later. Apoptosis, mitotic catastrophe, and senescence were determined according to
the characteristic nuclear morphologies (see ‘‘Materials and methods’’ for the definitions). (a) p53+/+ cells:
12.5%, 0% and 0% of cells showed apoptosis, mitotic catastrophe, and senescence, respectively. (b) p53-/-
cells: 0%, 12.8% and 0% of cells showed apoptosis, mitotic catastrophe, and senescence, respectively. The
arrows in (a) and (b) indicate cells undergoing apoptosis and mitotic catastrophe, respectively. Scale bars,
10 mm.
doi:10.1371/journal.pone.0115121.g003
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these cell lines showed a mitotic catastrophe-dominant phenotype upon
irradiation (Fig. 5). Taken together, these results indicate that dysfunction of the
p53 DNA-binding domain switches the mode of irradiation-induced cancer cell
death from apoptosis to mitotic catastrophe. These results also confirmed that
carbon-ion beam irradiation was better than X-ray irradiation at inducing mitotic
catastrophe in cancer cells harboring aberrant p53.
Cells are released from radiation-induced G2/M arrest 24 h after
X-ray or carbon-ion beam irradiation
Mitotic catastrophe is thought to occur when cells proceed through aberrant
mitosis with unrepaired DNA damage [26]. Therefore, to explore the mechanism
underlying the induction of mitotic catastrophe in p53-null cells by carbon-ion
beam irradiation, the effects of X-ray and carbon-ion beam irradiation on the cell
cycle statuses of p53+/+ and p53-/- HCT116 cells were determined by flow
cytometry (Fig. 6a, b). Like the cell death analyses, the cells were irradiated with
doses of X-ray (4 Gy) or carbon-ion beams (1.5 Gy). The induction of G2/M
arrest that peaked 12 h after irradiation was observed in both cell lines after X-ray
or carbon-ion beam irradiation, being more evident in the p53-/- cells than p53+/+
cells. Notably, in both cell lines exposed to X-ray or carbon-ion beam irradiation,
the G2/M arrest was fully released 48 h after irradiation.
Fig. 4. Mode of cell death induced by X-ray or carbon-ion beam irradiation in cancer cell lines with
differing p53 status. Cells were seeded on glass coverslips, incubated overnight, irradiated with X-rays (D10
dose) or carbon-ion beams (D10 dose), and then stained with DAPI 72 h later. Apoptosis, mitotic catastrophe,
and senescence were determined according to the characteristic nuclear morphologies (see ‘‘Materials and
methods’’ for the definitions). Data are expressed as the mean ¡ SD. Ap, apoptosis; MC, mitotic catastrophe;
Sns, senescence; IR, irradiation; C-ion, carbon-ion.
doi:10.1371/journal.pone.0115121.g004
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Next, the percentages of p53+/+ and p53-/- cells in the M phase before and after
X-ray (4 Gy) or carbon-ion beams (1.5 Gy) irradiation were assessed by
immunostaining using an antibody against pH3 (Fig. 6c) [24]. Approximately 2%
of non-irradiated p53+/+ and p53-/- cells were in the M phase. One hour after
carbon-ion beam irradiation, the percentages of these cells in the M phase were
reduced significantly, although p53-/- cells were less susceptible than p53+/+ cells to
X-ray irradiation. Notably, 24 h after X-ray or carbon-ion beam irradiation, the
percentages of p53+/+ and p53-/- cells in the M phase recovered to the baseline,
suggesting that both cell lines restarted mitosis 24 h after the treatment.
DNA double-strand breaks generated by carbon-ion beam
irradiation show slower repair kinetics than those generated by
X-ray irradiation
Finally, the repair kinetics of DNA double-strand breaks (DSBs), the most lethal
type of DNA damage generated by ionizing irradiation, were examined in p53+/+
and p53-/- HCT116 cells [27]. Irradiated cells were subjected to immunostaining
using an antibody against cH2AX, and the numbers of cH2AX foci per cell at
15 min and 24 h post-irradiation were counted (Fig. 7, S1 Table) [24, 28]. The
cells were irradiated with a 2 Gy dose of X-ray or a 1 Gy dose of carbon-ion
beams; at these doses, the number of cH2AX foci per cell at the control time point
(15 min post-irradiation) was approximately 20–30, which was appropriate for
Fig. 5. Mode of cell death induced by X-ray or carbon-ion beam irradiation in isogenic H1299 cells
expressing different p53 missense mutations. Cells were seeded on glass coverslips, incubated overnight,
irradiated with X-rays (10.9 Gy, D10 for X-rays; or 3.8 Gy, D10 for carbon-ion beams) or carbon-ion beams (3.8
Gy, D10 for carbon-ion beams), and then stained with DAPI 72 h later. Apoptosis, mitotic catastrophe, and
senescence were determined according to the characteristic nuclear morphologies (see ‘‘Materials and
methods’’ for the definitions). Data are expressed as the mean ¡ SD. MC, mitotic catastrophe; C-ion, carbon-
ion; IR, irradiation. Note that a part of p53-null H1299 panel is the same as that shown in Fig. 4 (but the
context is now different).
doi:10.1371/journal.pone.0115121.g005
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Fig. 6. Cell cycle profiles of p53+/+ and p53-/- HCT116 cells irradiated with X-rays or carbon-ion beams.
Cells were seeded in 35 mm culture plates (a, b) or on glass coverslips (c), incubated overnight, and exposed
(or not; 0 h) to X-ray (4 Gy) or carbon-ion beam (1.5 Gy) irradiation. (a, b) Cells irradiated with X-rays (a) or
carbon-ion beams (b) were incubated for 0, 12, 24, 48, 72, 96 or 120 h, fixed with ethanol, stained with
propidium iodide, and cell cycle status analyzed by flow cytometry. (c) Cells were irradiated with X-rays or
carbon-ion beams, incubated for 1 h, and then subjected to immunostaining for pH3, a specific marker for M
Carbon-Ion Beam-Induced Cell Death and p53 Status
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the assessment [24, 28]. Twenty four hours after X-ray irradiation, the numbers of
cH2AX foci in p53+/+ and p53-/- cells were 24¡4.3% and 23¡5.3% of those of
the corresponding controls (at the 15 min time point), respectively (Fig. 7a, b),
indicating that the large number of DSBs generated by X-ray irradiation were
repaired within 24 h. By contrast, 24 h after carbon-ion beam irradiation, the
numbers of cH2AX foci in p53+/+ and p53-/- cells were 93 ¡ 11% and 85¡7.3%
of those of the corresponding controls, respectively (Fig. 7a, c), indicating that the
DSBs generated by carbon-ion beam irradiation were not repaired efficiently,
probably due to the structural complexity of DSB ends [29]. Indeed, p53+/+ and
p53-/- cells that stained double-positive for cH2AX and pH 3 were identified 24 h
after carbon-ion beam irradiation, demonstrating that cells harboring DSBs had
entered mitosis (Fig. 7d). The p53 status did not affect the kinetics of the loss of
cH2AX foci after X-ray or carbon-ion beam irradiation. Taken together, these
data suggest that p53-null cells harboring unrepaired DSBs enter mitosis 24 h
after carbon-ion beam irradiation, leading to mitotic catastrophe.
Discussion
Here, we demonstrate that carbon-ion beam irradiation induces distinct modes of
cell death according to the mutation status of TP53. After both X-ray and carbon-
ion beam irradiation, apoptosis was the dominant mode of cell death of p53+/+
cells but not p53-/- cells. Notably, the rate of mitotic entry and the kinetics of DSB
repair after irradiation, which may be key factors that induce mitotic catastrophe,
were similar in p53+/+ and p53-/- cells regardless of the type of irradiation used.
These data indicate that apoptosis plays a primary role in cancer cell death caused
by irradiation in the presence of p53. In the absence of p53, cancer cells showed
resistance to apoptosis induction and mitotic catastrophe was observed after both
X-ray and carbon-ion beam irradiation. This finding is likely explained by
limitation of the G2/M checkpoint after irradiation. Activation of this checkpoint
allows the repair of damaged DNA before it is passed on to daughter cells and acts
as a barrier to prevent premature entry into mitosis [30]. However, previous
studies have suggested the limitation of G2/M checkpoint after IR; G2/M
checkpoint is released when the number of DSBs becomes lower than ,10–20,
followed by mitotic entry [24, 31]. Following the G2/M checkpoint release, cells
harboring 10–20 DSBs are able to complete the mitotic event and enter the G1
phase [32, 33]. DSB repair is downregulated in the M phase; therefore, this
damage may be repaired in the next cell cycle, although the repair process in
daughter cells remains to be elucidated [34]. Another possible reason for the
efficient induction of mitotic catastrophe in p53-/- cells is the higher propensity of
these cells to stall in the G2/M phase after irradiation than p53+/+ cells. This G2/M
phase cells. Data are expressed as the mean ¡ SD. *P,0.05 and {P,0.01 versus the corresponding
controls. IR, irradiation; C-ion, carbon-ion.
doi:10.1371/journal.pone.0115121.g006
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phase accumulation is the result of a defect in the p53-p21 signaling pathway that
attenuates G1 arrest after irradiation [16]. This property of p53-deficient cancer
cells might increase the chance of irradiated cells harboring unrepaired DSBs
entering mitosis, leading to the enhancement of mitotic catastrophe.
The results of the present study suggest that both a lack of p53 and missense
mutations in p53 contribute to the switch from apoptosis to mitotic catastrophe.
Overall, 75% of the p53 mutations identified in human cancers are single missense
mutations. Most missense mutations, including those examined in the present
study, are located within the p53 DNA-binding domain, which plays a key role in
the transcriptional activation of many target genes, including those that induce
apoptosis [25]. Most mutant p53 proteins have a dominant-negative effect,
leading to the dysfunction of the remaining normal p53 proteins. Therefore, it is
reasonable that, along with the lack of p53, missense mutations in the p53 DNA-
Fig. 7. Kinetics of DNA double-strand break generation by X-ray or carbon-ion beam irradiation in
p53+/+ and p53-/- HCT116 cells. Cells were seeded on glass coverslips, incubated overnight, exposed to X-
rays (2 Gy) or carbon-ion beams (1 Gy), incubated for an additional 15 min or 24 h, and then subjected to
immunostaining for cH2AX and pH3. Cells were then stained with DAPI. (a) Numbers of cH2AX foci per cell at
15 min or 24 h post-irradiation. The results for each cell line were normalized to the number of cH2AX foci at
the 15 min time point. At least 500 cells were counted per experimental condition. Data are expressed as the
mean ¡ SD. *P,0.05 versus the corresponding samples at 15 min. (b, c) Representative microscopic
images showing nuclei exposed to X-ray (b) or carbon-ion beam (c) irradiation, and immunostained for
cH2AX. In each panel, the outline of the nucleus detected by DAPI staining is indicated by a dashed line. (d)
Representative microscopic images of nuclei exposed to carbon-ion beam irradiation and immunostained for
cH2AX and pH 3 at 24 h post-irradiation. The arrows indicate double-positive nuclei. C-ion, carbon-ion.
doi:10.1371/journal.pone.0115121.g007
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binding domain also contribute to the apoptosis-resistant phenotype by
disrupting the ability of normal p53 proteins to transcriptionally activate
apoptosis-related genes; this may render irradiated cells harboring unrepaired
DSBs more susceptible to mitotic catastrophe. Nevertheless, it is worth noting a
study limitation at this point: we were not able to establish H1299 cells expressing
wild-type p53 (either transiently or stably); therefore, a comparison between wild-
type p53 and mutant p53 was impossible. Future studies should compare the
mode of irradiation-induced cell death in isogenic cell lines harboring wild-type,
mutant, and null-p53.
Of note, the results presented here demonstrate efficient induction of mitotic
catastrophe by carbon-ion beam irradiation in p53-null and p53-mutant cells. In
fact, in all the p53-null and p53-mutant cells lines tested, the dose that are
required to induce certain level of mitotic catastrophe was evidently lower in
carbon-ion beams than in X-rays. This result can be explained by the difficulties
associated with the repair of DSBs generated by carbon-ion beam irradiation,
which retain more complex structures of damaged DNA ends than those
generated by X-ray irradiation [35]. Inefficient DNA damage repair caused by the
complexity of the DSB ends may underlie the efficient cell-killing effect of carbon-
ion beam irradiation on cancer cells harboring p53 aberrations.
Fig. 8. Schematic model outlining the DNA damage response and cell death modes in p53 wild-type
and -null cells after X-ray or carbon-ion beam irradiation. C-ion, carbon-ion.
doi:10.1371/journal.pone.0115121.g008
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The results described here are partially contradictory to those of previous
studies that examined the DDR after carbon-ion beam irradiation of p53-mutant
cancer cells. Although a few studies observed efficient apoptosis (S2 Table) [12–
15], it should be noticed that this mode of cell death was only induced efficiently
at LET values greater than 70 keV/mm. By contrast, the average LET value at the
center of the clinically-used spread-out Bragg peak, as used here, is approximately
50 keV/mm. In addition, in contrast to the results described here, the induction of
senescence and prolonged (longer than 3 days) G2/M arrest was also observed in
previous studies using carbon-ion beam irradiation with high LET values [12, 36].
These data suggest that the DDR differs depending on the LET value of the
carbon-ion beam irradiation used. Additional in vitro and in vivo studies of a
variety of cell lines are required to validate the therapeutic effects of carbon-ion
beam irradiation at the LET used in clinical settings.
In summary, this comprehensive analysis of the DDR in irradiated isogenic cell
lines demonstrates that X-ray irradiation-resistant p53-null cancer cells are
susceptible to carbon-ion beam irradiation, which efficiently induces mitotic
catastrophe (Fig. 8). The induction of mitotic catastrophe in apoptosis-resistant
tumors may be an important biological advantage of carbon-ion radiotherapy
over X-ray radiotherapy. Additional studies using animal models or clinical
samples are required to elucidate this issue further.
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